Michael Broksgaard Jensen

Statistics

Publications

Citations

168

H-Index

Active since

2018

Affiliations

Rigshospitalet(Current)

Aalborg University Hospital

Danish Multiple Sclerosis Center

Aarhus University Hospital

Copenhagen University Hospital

Michael Broksgaard Jensen is an author at Rigshospitalet specializing in multiple sclerosis, multiple sclerosis therapy, and multiple sclerosis pharmacotherapy.

ORCID

Publications per year

2018–2021

Publications

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

Viktoria Papp, Zsolt Illés, Melinda Magyari et al. · Neurology · 2018 · 104 citations · Full text

Medicine, Neurology, Neuro-ophthalmology +14

Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study

Luigi Pontieri, Morten Blinkenberg, Stephan Bramow et al. · European Journal of Neurology · 2021 · 29 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +12

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Johanna Balslev Andersen, Sifat Sharmin, Mathilde Lefort et al. · Multiple Sclerosis and Related Disorders · 2021 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen et al. · CNS Drugs · 2021 · 12 citations

Medicine, Neurology, Pharmacotherapy +9

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

Elena Pedersen, Egon Stenager, JL Vadgaard et al. · Patient Preference and Adherence · 2018 · 11 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

1–5 of 5